Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clopidogrel and membranous nephropathy.

U Tholl, M Anlauf, U Helmchen

    Lancet (London, England)
    |October 30, 1999
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.

    Neuroendocrinology·2016
    Same author

    [Neuroendocrine neoplasms of the breast].

    Der Pathologe·2015
    Same author

    [Membranous nephropathy--crucial developments for diagnostic and treatment].

    Deutsche medizinische Wochenschrift (1946)·2014
    Same author

    [Neuroendocrine neoplasms of the distal jejunum and ileum].

    Der Pathologe·2014
    Same author

    Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2013
    Same author

    Secondary malignancy in patients with sporadic neuroendocrine neoplasia.

    Endocrine·2013

    Membranous nephropathy and nephrotic syndrome developed in a patient after starting clopidogrel treatment. Prior ticlopidine use may have sensitized the patient, contributing to this adverse drug reaction.

    Area of Science:

    • Nephrology
    • Pharmacology
    • Cardiology

    Background:

    • Membranous nephropathy is a common cause of nephrotic syndrome in adults.
    • Clopidogrel is an antiplatelet medication widely used after myocardial infarction.
    • Ticlopidine, a related antiplatelet agent, has known nephrotoxic potential.

    Observation:

    • A patient developed membranous nephropathy with nephrotic syndrome.
    • This occurred two months after initiating clopidogrel therapy for anterior myocardial infarction.
    • The patient had a history of prior treatment with ticlopidine.

    Findings:

    • The temporal association suggests clopidogrel may have triggered the nephropathy.
    • Prior ticlopidine exposure could have induced hypersensitivity, predisposing to clopidogrel-induced injury.

    Related Experiment Videos

  • This case highlights a potential drug-induced kidney injury mechanism involving related thienopyridines.

    • Implications:

    • Clinicians should consider drug-induced nephropathy in patients presenting with nephrotic syndrome after antiplatelet therapy.
    • Awareness of potential cross-reactivity or sensitization between ticlopidine and clopidogrel is crucial.
    • Further investigation into the immunopathogenesis of thienopyridine-associated membranous nephropathy is warranted.